Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,472.3
21.5 (0.88%)

 

  • STI Straits Times Index
    2,472.3
    21.5 (0.88%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,509.1
    8.3 (0.56%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    23,235.4
    -75.7 (-0.32%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,219.4
    -3.8 (-0.12%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,204.6
    116.8 (0.51%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    4,945.8
    103.0 (2.13%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,059.2M
  • Value: 869.4M
  • Rise: 172
  • Fall: 134
  • Unch: 475

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Jiutian Chemical0.051+0.005
Sembcorp Marine0.142-0.002
Alset0.062-0.001
Samko Timber0.034+0.001
Avarga0.260+0.015
AnAn Intl0.033+0.004
Addvalue Tech0.024+0.001
Rex Intl0.146+0.003
Singtel2.140+0.020
ThaiBev0.585-

World Indices

World Indices
Name Last Change
Nasdaq 10,672.3 +39.3
HSI 23,235.4 -75.7
HSCEI 9,302.6 -68.6
Jakarta 4,945.8 +103.0
Nikkei 225 23,204.6 +116.8
SSE Comp 3,219.4 -3.8
Shanghai A 3,374.1 -4.0
Shanghai B 247.4 +0.8
KOSPI 2,278.8 +6.1

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

INOZYME PHARMA INC INOZYME PHARMA
Updated on 25 Sep 2020 (End of trading day)
Last (USD): 22.000 Change: -0.250 High: 22.760 Remarks: -
Change (%): -1.12 Low: 21.250
Open 21.830 Yesterday's Close 22.25
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 13,910 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.84417 Trailing EPS (USD) e -0.84417 NAV (USD) b -2.1408
PE a - Trailing PE f - Price / NAV b -10.2765
Dividend (USD) d - Cash In Hand (USD) g 2.1769 Issued & Paid-up Shares c 23,364,900
Dividend Yield (%) d - Price / Cash In Hand g 10.106 Treasury Shares h -
Market Cap (M) 514.028 Enterprise Value (M) 561.726
Piotroski F Score 2 Exchange Code INZY Par Value ( $ ) n.a.
52 Weeks Volatility (%) n.a. Free Float (%) 41.0
Sector & Industry Health Technology - Pharmaceuticals: Major
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 25 Aug 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 22 Jul 2020.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference INOZYME PHARMA INC NASDAQ 514.028 - - -10.2765 -
Industry Pharmaceuticals: Major NASDAQ 2,600.863 114.250 71.024 4.0822 0.005
Local Peer ASTRAZENECA SPON ADR EACH REP 0.50 ORD SHS NASDAQ 145,690.436 - - - 2.468
Local Peer SANOFI SPON ADR ECH REP 0.5 ORD SHS NASDAQ 127,857.439 39.296 10.409 1.7983 2.302
Local Peer ROYALTY PHARMA PLC NASDAQ 24,326.737 10.358 10.358 5.8518 -
Local Peer CUREVAC NV NASDAQ 7,839.490 - - -163.6330 -
Local Peer REPLIGEN CORP NASDAQ 7,576.125 353.841 244.873 6.8872 -
Local Peer HUTCHISON CHINA MEDITECH SPON ADS EACH REPR 5 ORD SHS NASDAQ 4,675.715 - - 13.6668 -
Local Peer GRIFOLS SA SPON ADR EA REPR 1 ORD EUR0.10 NASDAQ 4,331.812 6.191 7.037 0.7189 2.680
Local Peer LEGEND BIOTECH CORP SPON ADS EACH REP 2 ORD SHS NASDAQ 4,104.067 - - 10.2347 -
Local Peer ALLAKOS INC NASDAQ 3,926.792 - - 8.7847 -
Local Peer TURNING POINT THERAPEUTICS INC NASDAQ 3,655.622 - - 5.1428 -
Local Peer PRINCIPIA BIOPHARMA INC NASDAQ 3,322.510 - - 9.4540 -
Local Peer REATA PHARMACEUTICALS INC NASDAQ 3,154.332 - - 13.6181 -
Other Local Peers NEKTAR THERAPEUTICS (NASDAQ), I MAB SPON ADS EACH REP 2.3 ORD SHS (NASDAQ), APELLIS PHARMACEUTICALS INC (NASDAQ), IGM BIOSCIENCES INC (NASDAQ), OPKO HEALTH INC (NASDAQ), HARMONY BIOSCIENCES HLDGS INC (NASDAQ), KARUNA THERAPEUTICS INC (NASDAQ), FORMA THERAPEUTICS HLDGS INC (NASDAQ), SPRINGWORKS THERAPEUTICS INC (NASDAQ), AKCEA THERAPEUTICS INC (NASDAQ), Y-MABS THERAPEUTICS INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), GENERATION BIO CO (NASDAQ), REPARE THERAPEUTICS INC (NASDAQ), ATHENEX INC (NASDAQ), NURIX THERAPEUTICS INC (NASDAQ), AKERO THERAPEUTICS INC (NASDAQ), KINIKSA PHARMACEUTICALS LTD (NASDAQ), QUANTERIX CORPORATION (NASDAQ), PHATHOM PHARMACEUTICALS INC (NASDAQ), ARCTURUS THERAPEUTICS HOLDINGS INC (NASDAQ), ARCUTIS BIOTHERAPEUTICS INC (NASDAQ), CONSTELLATION PHARMACEUTICALS INC (NASDAQ), GOSSAMER BIO INC (NASDAQ), PETIQ INC (NASDAQ), ANNEXON INC (NASDAQ), KEROS THERAPEUTICS INC (NASDAQ), KRYSTAL BIOTECH INC (NASDAQ), PHIBRO ANIMAL HEALTH CORP (NASDAQ), PROVENTION BIO INC (NASDAQ), TCR2 THERAPEUTICS INC (NASDAQ), ORIC PHARMACEUTICALS INC (NASDAQ), RELMADA THERAPEUTICS INC (NASDAQ), CALLIDITAS THERAPEUTICS AB SPON ADS EACH REP 2 ORD SHS (NASDAQ), SIGA TECHNOLOGIES INC (NASDAQ), ODONATE THERAPEUTICS INC (NASDAQ), FUSION PHARMACEUTICALS INC (NASDAQ), 89BIO INC (NASDAQ), OCULAR THERAPEUTIX INC (NASDAQ), APREA THERAPEUTICS INC (NASDAQ), OYSTER POINT PHARMA INC (NASDAQ), CRINETICS PHARMACEUTICALS INC (NASDAQ), MIRUM PHARMACEUTICALS INC (NASDAQ), G1 THERAPEUTICS IN (NASDAQ), BIONDVAX PHARMACEUTICALS SPON ADS REP 40 ORD SHS (NASDAQ), TRICIDA INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), KALA PHARMACEUTICALS INC (NASDAQ), ORCHARD THERAPEUTICS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), BEYONDSPRING INC (NASDAQ), TFF PHARMACEUTICALS INC (NASDAQ), AMRYT PHARMA PLC (NEW) SPON ADS EACH REP 5 ORD SHS (NASDAQ), IMARA INC (NASDAQ), BIOSPECIFICS TECHNOLOGIES CORP (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), SUTRO BIOPHARMA INC (NASDAQ), OVID THERAPEUTICS INC (NASDAQ), DURECT CORP (NASDAQ), AC IMMUNE SA (NASDAQ), IMMUNIC INC (NASDAQ), IDEAYA BIOSCIENCES INC (NASDAQ), OSMOTICA PHARMACEUTICALS PLC (NASDAQ), KALEIDO BIOSCIENCES INC (NASDAQ), AMAG PHARMACEUTICS INC (NASDAQ), UROVANT SCIENCES LTD (NASDAQ), XERIS PHARMACEUTICALS INC (NASDAQ), AQUESTIVE THERAPEUTICS INC (NASDAQ), HOOKIPA PHARMA INC (NASDAQ), VYNE THERAPEUTICS INC (NASDAQ), SPERO THERAPEUTICS INC (NASDAQ), KALVISTA PHARMACEUTICALS INC (NASDAQ), CYCLERION THERAPEUTICS INC (NASDAQ), FULCRUM THERAPEUTICS INC (NASDAQ), POLYPID LTD (NASDAQ), EVELO BIOSCIENCES INC (NASDAQ), VERRICA PHARMACEUTICALS INC (NASDAQ), GAMIDA CELL LTD (NASDAQ), GALERA THERAPEUTICS INC (NASDAQ), ESSA PHARMA INC (NASDAQ), SCPHARMACEUTICALS INC (NASDAQ), LIQUIDIA TECHNOLOGIES INC (NASDAQ), CHECKPOINT THERAPEUTICS INC (NASDAQ), MILESTONE PHARMACEUTICALS INC (NASDAQ), AVENUE THERAPEUTICS INC (NASDAQ), VERU INC (NASDAQ), MUSTANG BIO INC (NASDAQ), PROTARA THERAPEUTICS INC (NASDAQ), NEUBASE THERAPEUTICS INC (NASDAQ), ETON PHARMACEUTICALS INC (NASDAQ), THERATECHNOLOGIES INC (NASDAQ), SOL GEL TECHNOLOGIES LTD (NASDAQ), LOGICBIO THERAPEUTICS INC (NASDAQ), AYALA PHARMACEUTICALS INC (NASDAQ), HARROW HEALTH INC (NASDAQ), LYRA THERAPEUTICS INC (NASDAQ), OBSEVA SA (NASDAQ), GENPREX INC (NASDAQ), EVOLUS INC (NASDAQ), TYME TECHNOLOGIES INC (NASDAQ), LANTERN PHARMA INC (NASDAQ), CORVUS PHARMACEUTICALS INC (NASDAQ), GRITSTONE ONCOLOGY INC (NASDAQ), MEDIWOUND LTD (NASDAQ), PHASEBIO PHARMACEUTICALS INC (NASDAQ), EDESA BIOTECH INC (NASDAQ), EYENOVIA INC (NASDAQ), CLEARSIDE BIOMEDICAL INC (NASDAQ), TREVI THERAPEUTICS INC (NASDAQ), SATSUMA PHARMACEUTICALS INC (NASDAQ), ASSERTIO HOLDINGS INC (NASDAQ), EYEPOINT PHARMACEUTICALS INC (NASDAQ), KITOV PHARMA LTD SPON ADS EACH REP 10 ORD SHS (R/S) (NASDAQ), NOVAN INC (NASDAQ), ADDEX THERAPEUTICS LIMITED SPON ADS EACH REP 6 ORD SHS (NASDAQ), ADAMIS PHARMACEUTICALS CORPORATION (NASDAQ), ARIDIS PHARMACEUTICAL INC (NASDAQ), AERPIO PHARMACEUTICALS INC (NASDAQ), CITIUS PHARMACEUTICALS INC (NASDAQ), BAUDAX BIO INC (NASDAQ), AKARI THERAPEUTICS PLC SPON ADR EACH REPR 100 ORD (NASDAQ), PDS BIOTECHNOLOGY CORPORATION (NASDAQ), AILERON THERAPEUTICS INC (NASDAQ), MOLECULIN BIOTECH INC (NASDAQ), ALLENA PHARMACEUTICALS INC (NASDAQ), PAINREFORM LTD (NASDAQ), PROPHASE LABS INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), APTORUM GROUP LIMITED (NASDAQ), ONCTERNAL THERAPEUTICS INC (NASDAQ), MANNATECH INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), CNS PHARMACEUTICALS INC (NASDAQ), ACER THERAPEUTICS INC (NASDAQ), MILLENDO THERAPEUTICS INC (NASDAQ), SUN BIOPHARMA INC (NASDAQ), HOTH THERAPEUTICS INC (NASDAQ), ENTERA BIO LTD (NASDAQ), BRICKELL BIOTECH INC (NASDAQ), SPRING BANK PHARMACEUTICALS INC (NASDAQ), NOVUS THERAPEUTICS INC (NASDAQ), ADIAL PHARMACEUTICALS INC (NASDAQ), TITAN PHARMACEUTICAL INC (NASDAQ), CHINA SXT PHARMACEUTICALS INC (NASDAQ), TELIGENT INC NEW (NASDAQ)
Global Peer JOHNSON & JOHNSON NYSE 383,496.561 25.365 25.255 6.0894 2.574
Global Peer NOVARTIS AG ADR-EACH REPR 1 CHF0.5(REGD) NYSE 214,905.597 30.491 29.773 3.9937 2.115
Global Peer MERCK & CO INC NYSE 209,749.873 21.310 20.016 7.5881 2.736
Global Peer PFIZER INC NYSE 200,325.524 12.311 14.137 3.1137 4.033
Global Peer ABBVIE INC NYSE 152,181.291 19.406 22.049 10.3469 4.266
Global Peer ELI LILLY AND COMPANY NYSE 143,719.182 30.988 25.581 35.1140 1.719
Global Peer BRISTOL-MYERS SQUIBB CO NYSE 134,086.296 38.990 - 2.7312 2.792
Global Peer NOVO NORDISK A/S ADR-EACH CNV INTO 1 CLASS B DKK1 NYSE 125,175.394 21.437 20.408 13.8319 1.647
Global Peer GLAXOSMITHKLINE ADR EACH CNV INTO 2 ORD GBP0.25 NYSE 94,828.104 16.003 14.832 5.6460 5.160
Global Peer TAKEDA PHARMACEUTICAL CO LTD SPON ADS EACH REP 0.5 ORD SHS NYSE 58,421.013 143.577 59.119 1.3448 -
Other Global Peers WUXI APPTEC (HKEx), HANSOH PHARMA (HKEx), INNOVENT BIO (HKEx), CANSINOBIO-B (HKEx), SINOPHARM (HKEx), JUNSHI BIO (HKEx), SH PHARMA (HKEx), BAIYUNSHAN PH (HKEx), HYGEIA HEALTH (HKEx), BIOHAVEN PHARMACEUTICAL HLDG CO LTD (NYSE), HENLIUS-B (HKEx), CHINAGRANDPHARM (HKEx), CHINARES PHARMA (HKEx), CMS (HKEx), HEPALINK (HKEx), AKESO-B (HKEx), ADC THERAPEUTICS SA (NYSE), TRAD CHI MED (HKEx), ZYMEWORKS INC (NYSE), UNITED LAB (HKEx), OCUMENSION-B (HKEx), SSY GROUP (HKEx), INNOCARE-B (HKEx), AMNEAL PHARMACEUTICALS INC (NYSE), Kimia Farma Tbk. (IDX), CSTONE PHARMA-B (HKEx), CKLIFE SCIENCES (HKEx), Soho Global Health Tbk. (IDX), TONGRENTANGCM (HKEx), IMMUNOTECH-B (HKEx), HUA MEDICINE-B (HKEx), IGBB (Bursa), SHINEWAY PHARM (HKEx), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), STARPHARMA HOLDINGS LIMITED (ASX), FUSEN PHARM (HKEx), AFT PHARMACEUTICALS LTD (ASX), PYC THERAPEUTICS LIMITED (ASX), BSTEAD (Bursa), TOT BIOPHARM-B (HKEx), PHARMA (Bursa), LANNETT CO INC (NYSE), DAWNRAYS PHARMA (HKEx), ZHONGZHIPHARM (HKEx), CH BIOTECH SER (HKEx), BIOMX INC (NYSE American), RECCE PHARMACEUTICALS LTD (ASX), IX Biopharma (SGX), KOTRA (Bursa), Merck Tbk. (IDX), Hyphens Pharma (SGX), NEW RAY MEDIC (HKEx), Phapros Tbk. (IDX), IP (SET), ONCOSIL MEDICAL LIMITED (ASX), NEP INTERLONG (HKEx), PAK FAH YEOW (HKEx), RACE ONCOLOGY LTD (ASX), NOVA (Bursa), PALLA PHARMA LTD (ASX), CHARMACY PHAR (HKEx), BIOHLDG (Bursa), NOXOPHARM LTD (ASX), NC HEALTHCARE (HKEx), WAI YUEN TONG (HKEx), IMMURON LIMITED (ASX), TBG DIAGNOSTICS LTD (ASX), INVION LTD (ASX), SANAI HEALTH GP (HKEx), PURAPHARM (HKEx), EXTRAWELL PHAR (HKEx), MEDLAB CLINICAL LIMITED (ASX), JCT (SET), AGEX THERAPEUTICS INC (NYSE American), ANNOVIS BIO INC (NYSE American), EXOPHARM LTD (ASX), PHARMAXIS (ASX), SUNZEN (Bursa), ACRUX (ASX), FIJI KAVA LTD (ASX), SINOLIFE UTD (HKEx), PASHUN INT'L (HKEx), TALI DIGITAL LIMITED (ASX), TIMBER PHARMACEUTICALS INC (NYSE American), CRESO PHARMA LTD (ASX), SUDA PHARMACEUTICALS LTD (ASX), CELLMID LIMITED (ASX), Merck Sharp Dohme Pharma Tbk. (IDX), FARMAFORCE LTD (ASX), Pharmesis Intl (SGX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --1.970
-8.22 %
10 Days --2.230
-9.20 %
20 Days --6.720
-23.40 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 16.100 - 31.650 Change From 1 Year Low +5.900 % Change From 1 Year Low (%) +36.65
Change From 1 Year High -9.650 % Change From 1 Year High (%) -30.49
2 Years Range 16.100 - 31.650 Change From 2 Years Low +5.900 % Change From 2 Years Low (%) +36.65
Change From 2 Years High -9.650 % Change From 2 Years High (%) -30.49
5 Years Range 16.100 - 31.650 Change From 5 Years Low +5.900 % Change From 5 Years Low (%) +36.65
Change From 5 Years High -9.650 % Change From 5 Years High (%) -30.49
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Inozyme Pharma engages in the research and development of pharmaceutical products. It specializes in developing new medicines for the treatment of abnormal mineralization and ABCC6 deficiency. The company was founded by Axel Bolte, Joseph P. Schlessinger and Demetrios T. Braddock in September 2015 and is headquartered in Boston, MA.

Historical Price Data

Date Open High Low Close Volume VWAP
25 Sep 2020 21.830 22.760 21.250 22.000 13,910 -
24 Sep 2020 21.220 23.100 21.220 22.250 19,211 -
23 Sep 2020 22.440 22.960 21.258 21.690 38,395 -
22 Sep 2020 21.100 23.610 20.510 22.650 74,886 -
21 Sep 2020 23.070 24.000 20.569 20.800 85,970 -
18 Sep 2020 24.400 25.180 23.020 23.970 1,103,751 -
17 Sep 2020 22.460 25.090 21.620 24.400 106,654 -
16 Sep 2020 23.450 25.335 21.940 22.460 109,744 -
15 Sep 2020 24.190 25.190 21.115 23.530 75,328 -
14 Sep 2020 24.940 25.500 23.460 24.230 80,968 -
11 Sep 2020 24.730 25.000 24.010 24.230 56,411 -
10 Sep 2020 25.180 26.630 23.890 24.950 50,974 -
09 Sep 2020 28.480 30.060 24.610 25.460 145,713 -
08 Sep 2020 27.020 29.085 26.350 28.600 94,106 -
04 Sep 2020 28.630 28.660 24.600 27.630 160,787 -
03 Sep 2020 28.940 30.960 28.510 29.200 33,954 -
02 Sep 2020 30.400 30.500 29.090 29.290 48,798 -
01 Sep 2020 30.000 30.580 29.270 30.200 46,516 -
31 Aug 2020 29.000 30.425 29.000 29.980 51,024 -
28 Aug 2020 28.620 29.680 28.500 28.720 61,504 -
27 Aug 2020 29.000 29.010 27.291 28.490 15,573 -
26 Aug 2020 27.600 29.050 26.830 28.640 15,621 -
Summary
Current 2 Weeks
(14 Sep 2020 to 25 Sep 2020)
24.940 25.500 20.510 22.000 1,708,817 -
Previous 2 Weeks
(28 Aug 2020 to 11 Sep 2020)
28.620 29.680 20.510 24.230 749,787 -
4 Weeks from
(31 Jul 2020 to 27 Aug 2020)
19.900 25.500 19.010 28.490 1,849,718 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.